FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert Sidwell

Research Profile

Chemicals & Drugs

Living Beings

Physiology

Virus Replication

Disorders

Anatomy

Procedures

Administration, Oral

Co-author Network

Publications

TOP 3
Dale L Barnard; Craig W Day; Kevin Bailey; Matthew Heiner; Robert Montgomery; Larry Lauridsen; Kie-Hoon Jung; Joseph K-K Li; Paul K S Chan; Robert W Sidwell
Is the anti-psychotic, 10-(3-(dimethylamino)propyl)phenothiazine (promazine), a potential drug with which to treat SARS infections? Lack of efficacy of promazine on SARS-CoV replication in a mouse model.
Donald F Smee; Brian B Gowen; Miles K Wandersee; Min-Hui Wong; Ramona T Skirpstunas; Thomas J Baldwin; Justin D Hoopes; Robert W Sidwell
Differential pathogenesis of cowpox virus intranasal infections in mice induced by low and high inoculum volumes and effects of cidofovir treatment.
Brian B Gowen; Min-Hui Wong; Kie-Hoon Jung; Lawrence M Blatt; Robert W Sidwell
Prophylactic and therapeutic intervention of Punta Toro virus (Phlebovirus, Bunyaviridae) infection in hamsters with interferon alfacon-1.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert Sidwell (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Dale L Barnard; Craig W Day; Kevin Bailey; Matthew Heiner; Robert Montgomery; Larry Lauridsen; Kie-Hoon Jung; Joseph K-K Li; Paul K S Chan; Robert W Sidwell
Is the anti-psychotic, 10-(3-(dimethylamino)propyl)phenothiazine (promazine), a potential drug with which to treat SARS infections? Lack of efficacy of promazine on SARS-CoV replication in a mouse model.
Antiviral research 2008;79(2):105-13.
2008: Donald F Smee; Brian B Gowen; Miles K Wandersee; Min-Hui Wong; Ramona T Skirpstunas; Thomas J Baldwin; Justin D Hoopes; Robert W Sidwell
Differential pathogenesis of cowpox virus intranasal infections in mice induced by low and high inoculum volumes and effects of cidofovir treatment.
International journal of antimicrobial agents 2008;31(4):352-9.
2008: Brian B Gowen; Min-Hui Wong; Kie-Hoon Jung; Lawrence M Blatt; Robert W Sidwell
Prophylactic and therapeutic intervention of Punta Toro virus (Phlebovirus, Bunyaviridae) infection in hamsters with interferon alfacon-1.
Antiviral research 2008;77(3):215-24.
2008: G. SUBRAMANIAN; Paul Moore; Brian B Gowen; Aaron L Olsen; Dale L Barnard; Jason Paragas; Robert Jeffrey Hogan; Robert W Sidwell
Potent in vitro activity of the albumin fusion type 1 interferons (albumin-interferon-alpha and albumin-interferon-beta) against RNA viral agents of bioterrorism and the severe acute respiratory syndrome (SARS) virus.
Chemotherapy 2008;54(3):176-80.
2008: S Hossein Fatemi; Teri J Reutiman; Timothy D Folsom; Robert W Sidwell
The role of cerebellar genes in pathology of autism and schizophrenia.
Cerebellum (London, England) 2008;7(3):279-94.
2007: Donald F Smee; Brett L Hurst; Min-Hui Wong; Robert I Glazer; Aquilur Rahman; Robert W Sidwell
Efficacy of N-methanocarbathymidine in treating mice infected intranasally with the IHD and WR strains of vaccinia virus.
Antiviral research 2007;76(2):124-9.
2007: Brian B Gowen; Min-Hui Wong; Kie-Hoon Jung; Andrew B Sanders; Michelle Mendenhall; Kevin W Bailey; Yousuke Furuta; Robert W Sidwell
In vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections.
Antimicrobial agents and chemotherapy 2007;51(9):3168-76.
2007: Aaron L Olsen; John D Morrey; Donald F Smee; Robert W Sidwell
Correlation between breakdown of the blood-brain barrier and disease outcome of viral encephalitis in mice.
Antiviral research 2007;75(2):104-12.
2007: Justin G Julander; John W Judge; Aaron L Olsen; Barnett Rosenberg; Kristiina Schafer; Robert W Sidwell
Prophylactic treatment with recombinant Eimeria protein, alone or in combination with an agonist cocktail, protects mice from Banzi virus infection.
Antiviral research 2007;75(1):14-9.
2007: Justin G Julander; Yousuke Furuta; Kristiina Shafer; Robert W Sidwell
Activity of T-1106 in a hamster model of yellow Fever virus infection.
Antimicrobial agents and chemotherapy 2007;51(6):1962-6.
2007: Brian B Gowen; Min-Hui Wong; Kie-Hoon Jung; Andrew B Sanders; William M Mitchell; Lena Alexopoulou; Richard A Flavell; Robert W Sidwell
TLR3 is essential for the induction of protective immunity against Punta Toro Virus infection by the double-stranded RNA (dsRNA), poly(I:C12U), but not Poly(I:C): differential recognition of synthetic dsRNA molecules.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(8):5200-8.
2007: Justin G Julander; Venkatraman Siddharthan; Lawrence M Blatt; Kristiina Schafer; Robert W Sidwell; John D Morrey
Effect of exogenous interferon and an interferon inducer on western equine encephalitis virus disease in a hamster model.
Virology 2007;360(2):454-60.
2007: Robert W Sidwell; Dale L Barnard; Craig W Day; Donald F Smee; Kevin W Bailey; Min-Hui Wong; John D Morrey; Yousuke Furuta
Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice.
Antimicrobial agents and chemotherapy 2007;51(3):845-51.
2007: Justin G Julander; John D Morrey; Lawrence M Blatt; Kristiina Shafer; Robert W Sidwell
Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model.
Antiviral research 2007;73(2):140-6.
2007: Dale L Barnard; Min-Hui Wong; Kevin Bailey; Craig W Day; Robert W Sidwell; Stephen S Hickok; Tony J Hall
Effect of oral gavage treatment with ZnAL42 and other metallo-ion formulations on influenza A H5N1 and H1N1 virus infections in mice.
Antiviral chemistry & chemotherapy 2007;18(3):125-32.
2007: Donald F Smee; Miles K Wandersee; Kevin W Bailey; Min-Hui Wong; Chung (David) K. Chu; Srinivas Gadthula; Robert W Sidwell
Cell line dependency for antiviral activity and in vivo efficacy of N-methanocarbathymidine against orthopoxvirus infections in mice.
Antiviral research 2007;73(1):69-77.
2006: Brian B Gowen; Justin D Hoopes; Min-Hui Wong; Kie-Hoon Jung; Kevin C Isakson; Lena Alexopoulou; Richard A Flavell; Robert W Sidwell
TLR3 deletion limits mortality and disease severity due to Phlebovirus infection.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(9):6301-7.
2006: Robert W Sidwell; Dale L Barnard
Respiratory syncytial virus infections: recent prospects for control.
Antiviral research 2006;71(2-3):379-90.
2006: Dale L Barnard; Craig W Day; Kevin Bailey; Matthew Heiner; Robert Montgomery; Larry Lauridsen; Scott G Winslow; Justin Hoopes; Joseph K-K Li; Jongdae Lee; Dennis A Carson; Howard B Cottam; Robert W Sidwell
Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin.
Antiviral research 2006;71(1):53-63.
2006: Brian B Gowen; Donald F Smee; Min-Hui Wong; John W Judge; Kie-Hoon Jung; Kevin W Bailey; Anne M Pace; Barnett Rosenberg; Robert W Sidwell
Recombinant Eimeria protozoan protein elicits resistance to acute phlebovirus infection in mice but not hamsters.
Antimicrobial agents and chemotherapy 2006;50(6):2023-9.
2006: Michael P Malakhov; Laura Aschenbrenner; Donald F Smee; Miles K Wandersee; Robert W Sidwell; Larisa V Gubareva; Vasiliy Mishin; Frederick G Hayden; Do Hyong Kim; Alice Ing; Erin R Campbell; Mang Yu; Fang Fang
Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection.
Antimicrobial agents and chemotherapy 2006;50(4):1470-9.
2006: Justin G Julander; Quinton A Winger; Lee F Rickords; Pei-Yong Shi; Mark Tilgner; Iwona Binduga-Gajewska; Robert W Sidwell; John D Morrey
West Nile virus infection of the placenta.
Virology 2006;347(1):175-82.
2006: Brian B Gowen; Jeff Fairman; Donald F Smee; Min-Hui Wong; Kie-Hoon Jung; Anne M Pace; Matthew Heiner; Kevin W Bailey; Steven W Dow; Robert W Sidwell
Protective immunity against acute phleboviral infection elicited through immunostimulatory cationic liposome-DNA complexes.
Antiviral research 2006;69(3):165-72.
2006: Chung (David) K. Chu; Srinivas Gadthula; Xin Chen; Hyunah Choo; Süreyya Olgen; Dale L Barnard; Robert W Sidwell
Antiviral activity of nucleoside analogues against SARS-coronavirus (SARS-coV).
Antiviral chemistry & chemotherapy 2006;17(5):285-9.
2006: Dale L Barnard; Craig W Day; Kevin Bailey; Matthew Heiner; Robert Montgomery; Larry Lauridsen; Paul K S Chan; Robert W Sidwell
Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice.
Antiviral chemistry & chemotherapy 2006;17(5):275-84.
2006: Periyasamy Selvam; Narayanan Murugesh; Markandavel Chandramohan; Robert W Sidwell; Miles K Wandersee; Donald F Smee
Anti-influenza virus activities of 4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)amino]-N-(4,6-dimethyl-2-pyrimidin-2-yl)benzenesulphonamide and its derivatives.
Antiviral chemistry & chemotherapy 2006;17(5):269-74.
2006: Donald F Smee; Min-Hui Wong; Kevin W Bailey; Robert W Sidwell
Activities of oseltamivir and ribavirin used alone and in combination against infections in mice with recent isolates of influenza A (H1N1) and B viruses.
Antiviral chemistry & chemotherapy 2006;17(4):185-92.
2006: Brian B Gowen; Donald F Smee; Min-Hui Wong; Anne M Pace; Kie-Hoon Jung; Kevin W Bailey; Lawrence M Blatt; Robert W Sidwell
Combinatorial ribavirin and interferon alfacon-1 therapy of acute arenaviral disease in hamsters.
Antiviral chemistry & chemotherapy 2006;17(4):175-83.
2005: Robert W Sidwell; Kevin W Bailey; Min-Hui Wong; Dale L Barnard; Donald F Smee
In vitro and in vivo influenza virus-inhibitory effects of viramidine.
Antiviral research 2005;68(1):10-7.
2005: Craig W Day; Donald F Smee; Justin G Julander; Vladimir Yamshchikov; Robert W Sidwell; John D Morrey
Error-prone replication of West Nile virus caused by ribavirin.
Antiviral research 2005;67(1):38-45.
2005: Brian B Gowen; Dale L Barnard; Donald F Smee; Min-Hui Wong; Anne M Pace; Kie-Hoon Jung; Scott G Winslow; Kevin W Bailey; Lawrence M Blatt; Robert W Sidwell
Interferon alfacon-1 protects hamsters from lethal pichinde virus infection.
Antimicrobial agents and chemotherapy 2005;49(6):2378-86.
2005: Justin G Julander; Quinton A Winger; Aaron L Olsen; Craig W Day; Robert W Sidwell; John D Morrey
Treatment of West Nile virus-infected mice with reactive immunoglobulin reduces fetal titers and increases dam survival.
Antiviral research 2005;65(2):79-85.
2005: Donald F Smee; Miles K Wandersee; Kevin W Bailey; Karl Y Hostetler; Antonin Holy; Robert W Sidwell
Characterization and treatment of cidofovir-resistant vaccinia (WR strain) virus infections in cell culture and in mice.
Antiviral chemistry & chemotherapy 2005;16(3):203-11.
2004: Peiyuan Wang; Laurent Hollecker; Krzysztof W Pankiewicz; Steven E Patterson; Tony Whitaker; Tamara R McBrayer; Phillip M Tharnish; Robert W Sidwell; Lieven Stuyver; Michael J Otto; Ray F Schinazi; Kyoichi A Watanabe
Synthesis of N3,5'-cyclo-4-(beta-D-ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one, a novel compound with anti-hepatitis C virus activity.
Journal of medicinal chemistry 2004;47(24):6100-3.
2004: Donald F Smee; Kevin W Bailey; Min-Hui Wong; Miles K Wandersee; Robert W Sidwell
Topical cidofovir is more effective than is parenteral therapy for treatment of progressive vaccinia in immunocompromised mice.
The Journal of infectious diseases 2004;190(6):1132-9.
2004: Donald F Smee; Miles K Wandersee; Min-Hui Wong; Kevin W Bailey; Robert W Sidwell
Treatment of mannan-enhanced influenza B virus infections in mice with oseltamivir, ribavirin and viramidine.
Antiviral chemistry & chemotherapy 2004;15(5):261-8.
2004: John D Morrey; Craig W Day; Justin G Julander; Aaron L Olsen; Robert W Sidwell; Carl D Cheney; Lawrence M Blatt
Modeling hamsters for evaluating West Nile virus therapies.
Antiviral research 2004;63(1):41-50.
2004: Donald F Smee; Min-Hui Wong; Kevin W Bailey; James R Beadle; Karl Y Hostetler; Robert W Sidwell
Effects of four antiviral substances on lethal vaccinia virus (IHD strain) respiratory infections in mice.
International journal of antimicrobial agents 2004;23(5):430-7.
2004: Dale L Barnard; V D Hubbard; Donald F Smee; Robert W Sidwell; Keith G Watson; Simon P Tucker; Phillip A Reece
In vitro activity of expanded-spectrum pyridazinyl oxime ethers related to pirodavir: novel capsid-binding inhibitors with potent antipicornavirus activity.
Antimicrobial agents and chemotherapy 2004;48(5):1766-72.
2004: John D Morrey; Craig W Day; Justin G Julander; Lawrence M Blatt; Donald F Smee; Robert W Sidwell
Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models.
Antiviral chemistry & chemotherapy 2004;15(2):101-9.
2004: Dale L Barnard; Valerie D Hubbard; Jared Burton; Donald F Smee; John D Morrey; Michael J Otto; Robert W Sidwell
Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and beta-D-N4-hydroxycytidine.
Antiviral chemistry & chemotherapy 2004;15(1):15-22.
2004: Donald F Smee; Robert W Sidwell
Anti-cowpox virus activities of certain adenosine analogs, arabinofuranosyl nucleosides, and 2'-fluoro-arabinofuranosyl nucleosides.
Nucleosides, nucleotides & nucleic acids 2004;23(1-2):375-83.
2003: Robert W Sidwell; Kevin W Bailey; John D Morrey; Min-Hui Wong; Thomas J Baldwin; Donald F Smee
Inhibition of influenza virus infections in immunosuppressed mice with orally administered peramivir (BCX-1812).
Antiviral research 2003;60(1):17-25.
2003: Justin G Julander; Richard J Colonno; Robert W Sidwell; John D Morrey
Characterization of antiviral activity of entecavir in transgenic mice expressing hepatitis B virus.
Antiviral research 2003;59(3):155-61.
2003: Keith G Watson; Renee N Brown; Rachel Cameron; David K Chalmers; Stephanie Hamilton; Betty Jin; Guy Y Krippner; Angela Luttick; Darryl B McConnell; Phillip A Reece; Jane Ryan; Pauline C Stanislawski; Simon P Tucker; Wen-Yang Wu; Dale L Barnard; Robert W Sidwell
An orally bioavailable oxime ether capsid binder with potent activity against human rhinovirus.
Journal of medicinal chemistry 2003;46(15):3181-4.
2003: Donald F Smee; Kevin W Bailey; Robert W Sidwell
Comparative effects of cidofovir and cyclic HPMPC on lethal cowpox and vaccinia virus respiratory infections in mice.
Chemotherapy 2003;49(3):126-31.
2003: Robert W Sidwell; Donald F Smee
Viruses of the Bunya- and Togaviridae families: potential as bioterrorism agents and means of control.
Antiviral research 2003;57(1-2):101-11.
2003: Donald F Smee; Robert W Sidwell
A review of compounds exhibiting anti-orthopoxvirus activity in animal models.
Antiviral research 2003;57(1-2):41-52.
2002: Donald F Smee; Ann C Morrison; Dale L Barnard; Robert W Sidwell
Comparison of colorimetric, fluorometric, and visual methods for determining anti-influenza (H1N1 and H3N2) virus activities and toxicities of compounds.
Journal of virological methods 2002;106(1):71-9.
2002: John D Morrey; Donald F Smee; Robert W Sidwell; Christopher Tseng
Identification of active antiviral compounds against a New York isolate of West Nile virus.
Antiviral research 2002;55(1):107-16.
2002: Justin G Julander; Robert W Sidwell; John D Morrey
Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B virus.
Antiviral research 2002;55(1):27-40.
2002: Robert W Sidwell; Donald F Smee
Peramivir (BCX-1812, RWJ-270201): potential new therapy for influenza.
Expert opinion on investigational drugs 2002;11(6):859-69.
2002: Donald F Smee; Kevin W Bailey; Robert W Sidwell
Treatment of lethal cowpox virus respiratory infections in mice with 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine and its orally active diacetate ester prodrug.
Antiviral research 2002;54(2):113-20.
2002: Donald F Smee; Kevin W Bailey; Ann C Morrison; Robert W Sidwell
Combination treatment of influenza A virus infections in cell culture and in mice with the cyclopentane neuraminidase inhibitor RWJ-270201 and ribavirin.
Chemotherapy 2002;48(2):88-93.
2002: Donald F Smee; Robert W Sidwell; Deborah Kefauver; Mike Bray; John W Huggins
Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses.
Antimicrobial agents and chemotherapy 2002;46(5):1329-35.
2002: Dale L Barnard; Ze-Qi Xu; Valerie D Stowell; Hongwei Yuan; Donald F Smee; Raghu Samy; Robert W Sidwell; M Kim Nielsen; Lihui Sun; Hua Cao; Ailing Li; Clay Quint; Jeffrey Deignan; Jennifer Crabb; Michael T Flavin
Coumarins and pyranocoumarins, potential novel pharmacophores for inhibition of measles virus replication.
Antiviral chemistry & chemotherapy 2002;13(1):39-59.
2001: Donald F Smee; Robert W Sidwell; Ann C Morrison; Kevin W Bailey; Ellen Z Baum; L Ly; Pamela C Wagaman
Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201.
Antiviral research 2001;52(3):251-9.
2001: Robert W Sidwell; Min-Hui Wong; Kevin W Bailey; Dale L Barnard; M K Jackson; Donald F Smee
Utilization of alpha-1-acid glycoprotein levels in the serum as a parameter for in vivo assay of influenza virus inhibitors.
Antiviral chemistry & chemotherapy 2001;12(6):359-65.
2001: Donald F Smee; Kevin W Bailey; Min-Hui Wong; Robert W Sidwell
Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice.
Antiviral research 2001;52(1):55-62.
2001: Robert W Sidwell; Donald F Smee; JH Huffman; Dale L Barnard; John D Morrey; Kevin W Bailey; W C Feng; Y S Babu; K Bush
Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201.
Antiviral research 2001;51(3):179-87.
2001: Dale L Barnard; V D Stowell; KL Seley; V R Hegde; Subha R Das; Vasanthakumar Rajappan; Stewart W Schneller; Donald F Smee; Robert W Sidwell
Inhibition of measles virus replication by 5'-nor carbocyclic adenosine analogues.
Antiviral chemistry & chemotherapy 2001;12(4):241-50.
2001: Robert W Sidwell; Donald F Smee; Kevin W Bailey; R A Burger
Primary immune system effects of the orally administered cyclopentane neuraminidase inhibitor RWJ-270201 in influenza virus-infected mice.
International immunopharmacology 2001;1(6):1211-8.
2001: Robert W Sidwell; Donald F Smee; JH Huffman; Dale L Barnard; Kevin W Bailey; John D Morrey; Y S Babu
In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201.
Antimicrobial agents and chemotherapy 2001;45(3):749-57.
2001: Donald F Smee; JH Huffman; Ann C Morrison; Dale L Barnard; Robert W Sidwell
Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities.
Antimicrobial agents and chemotherapy 2001;45(3):743-8.
2001: Donald F Smee; Kevin W Bailey; Robert W Sidwell
Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir.
Antiviral chemistry & chemotherapy 2001;12(1):71-6.
2000: Robert W Sidwell; Donald F Smee
In vitro and in vivo assay systems for study of influenza virus inhibitors.
Antiviral research 2000;48(1):1-16.
2000: S Yasuda; JH Huffman; Donald F Smee; Robert W Sidwell; K Miyata
Spectrum of virus inhibition by consensus interferon YM643.
Antiviral chemistry & chemotherapy 2000;11(5):337-41.
2000: Donald F Smee; Kevin W Bailey; M Wong; Robert W Sidwell
Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir.
Antiviral research 2000;47(3):171-7.
2000: Donald F Smee; Kevin W Bailey; Robert W Sidwell
Treatment of cowpox virus respiratory infections in mice with ribavirin as a single agent or followed sequentially by cidofovir.
Antiviral chemistry & chemotherapy 2000;11(4):303-9.
2000: R A Burger; J L Billingsley; JH Huffman; Kevin W Bailey; Choung U Kim; Robert W Sidwell
Immunological effects of the orally administered neuraminidase inhibitor oseltamivir in influenza virus-infected and uninfected mice.
Immunopharmacology 2000;47(1):45-52.
1999: Robert W Sidwell; Kevin W Bailey; P A Bemis; Min-Hui Wong; E J Eisenberg; JH Huffman
Influence of treatment schedule and viral challenge dose on the in vivo influenza virus-inhibitory effects of the orally administered neuraminidase inhibitor GS 4104.
Antiviral chemistry & chemotherapy 1999;10(4):187-93.
1999: John D Morrey; Kevin W Bailey; Brent E Korba; Robert W Sidwell
Utilization of transgenic mice replicating high levels of hepatitis B virus for antiviral evaluation of lamivudine.
Antiviral research 1999;42(2):97-108.
1999: Dale L Barnard; Robert W Sidwell; W Xiao; MR Player; S A Adah; Paul F Torrence
2-5A-DNA conjugate inhibition of respiratory syncytial virus replication: effects of oligonucleotide structure modifications and RNA target site selection.
Antiviral research 1999;41(3):119-34.
1999: M K Jackson; E A Mitchell; Scott G Winslow; K M Okelberry; Robert W Sidwell; John D Morrey
Resistance to Friend leukemia virus in transgenic mice expressing the native Fv-4 gene.
Acta virologica 1999;43(1):19-23.
1998: Chun Y Tai; PA Escarpe; Robert W Sidwell; MA Williams; W Lew; H Wu; Choung U Kim; Dirk B Mendel
Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071.
Antimicrobial agents and chemotherapy 1998;42(12):3234-41.
1998: Dirk B Mendel; Chun Y Tai; PA Escarpe; W Li; Robert W Sidwell; JH Huffman; Clive Sweet; Kenneth J Jakeman; J Merson; S A Lacy; W Lew; MA Williams; L Zhang; MS Chen; Norbert Bischofberger; Choung U Kim
Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection.
Antimicrobial agents and chemotherapy 1998;42(3):640-6.
1998: Robert W Sidwell; JH Huffman; Dale L Barnard; Kevin W Bailey; Min-Hui Wong; A Morrison; T Syndergaard; Choung U Kim
Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor.
Antiviral research 1998;37(2):107-20.
1998: John D Morrey; Brent E Korba; Robert W Sidwell
Transgenic mice as a chemotherapeutic model for hepatitis B virus infection.
Antiviral therapy 1998;3(Suppl 3):59-68.
1997: Dale L Barnard; Craig L Hill; T Gage; J E Matheson; JH Huffman; Robert W Sidwell; M I Otto; Ray F Schinazi
Potent inhibition of respiratory syncytial virus by polyoxometalates of several structural classes.
Antiviral research 1997;34(1):27-37.
1997: A K Judd; A Sanchez; D J Bucher; JH Huffman; K Bailey; Robert W Sidwell
In vivo anti-influenza virus activity of a zinc finger peptide.
Antimicrobial agents and chemotherapy 1997;41(3):687-92.
1996: D F Smee; Robert W Sidwell; B B Barnett
Combination of antiviral immunotoxin and ganciclovir or cidofovir for the treatment of murine cytomegalovirus infections.
Antiviral research 1996;32(3):165-71.
1996: Robert W Sidwell; JH Huffman; Kevin W Bailey; Min-Hui Wong; A Nimrod; A Panet
Inhibitory effects of recombinant manganese superoxide dismutase on influenza virus infections in mice.
Antimicrobial agents and chemotherapy 1996;40(11):2626-31.
1996: D F Smee; Robert W Sidwell; JH Huffman; J W Huggins; M Kende; A J Verbiscar
Antiviral activities of tragacanthin polysaccharides on Punta Toro virus infections in mice.
Chemotherapy 1996;42(4):286-93.
1996: B B Barnett; D F Smee; S M Malek; Robert W Sidwell
Selective cytotoxicity of ricin A chain immunotoxins towards murine cytomegalovirus-infected cells.
Antimicrobial agents and chemotherapy 1996;40(2):470-2.
1995: Dale L Barnard; D W Fairbairn; Kim L O'Neill; T L Gage; Robert W Sidwell
Anti-human cytomegalovirus activity and toxicity of sulfonated anthraquinones and anthraquinone derivatives.
Antiviral research 1995;28(4):317-29.
1995: Robert W Sidwell; Kevin W Bailey; Min-Hui Wong; JH Huffman
In vitro and in vivo sensitivity of a non-mouse-adapted influenza A (Beijing) virus infection to amantadine and ribavirin.
Chemotherapy 1995;41(6):455-61.
1995: B B Barnett; D F Smee; S M Malek; Robert W Sidwell
Selective cytotoxicity towards cytomegalovirus-infected cells by immunotoxins consisting of gelonin linked to anti-cytomegalovirus antibody.
Antiviral research 1995;28(1):93-100.
1995: R A Burger; RP Warren; JH Huffman; Robert W Sidwell
Effect of methionine enkephalin on natural killer cell and cytotoxic T lymphocyte activity in mice infected with influenza A virus.
Immunopharmacology and immunotoxicology 1995;17(2):323-34.
1995: M A Chirigos; EYAL TALOR; Robert W Sidwell; R A Burger; RP Warren
Leukocyte Interleukin, Inj. (LI) augmentation of natural killer cells and cytolytic T-lymphocytes.
Immunopharmacology and immunotoxicology 1995;17(2):247-64.
1995: Robert W Sidwell; RP Warren; K Okleberry; R A Burger; John D Morrey
Effect of the combination of interferon-alpha and stavudine on Friend virus infections in (B10.A x A.By)F1 mice.
The Journal of infectious diseases 1995;171 Suppl 2():S93-8.
1995: D F Smee; S T Sugiyama; Robert W Sidwell; B B Barnett
Effects of monoclonal antibody combined with ganciclovir or (S)-1-[3-hydroxy-(2-phosphonylmethoxy)-propyl]cytosine against murine cytomegalovirus infections in cell culture and in severe combined immunodeficient mice.
Chemotherapy 1995;41(2):141-8.
1995: Robert W Sidwell; D F Smee; JH Huffman; Kevin W Bailey; RP Warren; R A Burger; C L Penney
Antiviral activity of an immunomodulatory lipophilic desmuramyl dipeptide analog.
Antiviral research 1995;26(2):145-59.
1995: D F Smee; B B Barnett; Robert W Sidwell; E J Reist; A Holy
Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus.
Antiviral research 1995;26(1):1-9.
1994: Robert W Sidwell; JH Huffman; Dale L Barnard; D F Smee; RP Warren; M A Chirigos; M Kende; J Huggins
Antiviral and immunomodulating inhibitors of experimentally-induced Punta Toro virus infections.
Antiviral research 1994;25(2):105-22.
1994: J W Lillie; D F Smee; JH Huffman; L J Hansen; Robert W Sidwell; R Kaddurah-Daouk
Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits the replication of human herpes viruses.
Antiviral research 1994;23(3-4):203-18.
1994: John D Morrey; S M Bourn; J L Morris; Thomas D Bunch; Robert W Sidwell
Activation of the human immunodeficiency virus long terminal repeat by abrasion of the skin in transgenic mice.
Intervirology 1994;37(6):315-20.
1994: Robert W Sidwell; JH Huffman; B J Moscon; RP Warren
Influenza virus-inhibitory effects of intraperitoneally and aerosol-administered SP-303, a plant flavonoid.
Chemotherapy 1994;40(1):42-50.
1993: Dale L Barnard; JH Huffman; Robert W Sidwell; E J Reist
Selective inhibition of cytomegaloviruses by 9-(3'-ethylphosphono-1'-hydroxymethyl-1'-propyloxy-methyl)g uanine.
Antiviral research 1993;22(1):77-89.
1993: Robert W Sidwell; John D Morrey; K M Okleberry; R A Burger; RP Warren
Immunomodulator effects on the Friend virus infection in genetically defined mice.
Annals of the New York Academy of Sciences 1993;685():432-46.
1993: Dale L Barnard; JH Huffman; L R Meyerson; Robert W Sidwell
Mode of inhibition of respiratory syncytial virus by a plant flavonoid, SP-303.
Chemotherapy 1993;39(3):212-7.
1993: Dale L Barnard; D F Smee; JH Huffman; L R Meyerson; Robert W Sidwell
Antiherpesvirus activity and mode of action of SP-303, a novel plant flavonoid.
Chemotherapy 1993;39(3):203-11.
1993: Robert W Sidwell; D F Smee; RP Warren; JH Huffman; B J Gilbert; R A Burger; F C Pearson
Murine cytomegalovirus-inhibitory effects of ImuVert.
Antiviral research 1993;20(4):279-92.
1993: D F Smee; J Gilbert; J A Leonhardt; B B Barnett; J H Huggins; Robert W Sidwell
Treatment of lethal Pichinde virus infections in weanling LVG/Lak hamsters with ribavirin, ribamidine, selenazofurin, and ampligen.
Antiviral research 1993;20(1):57-70.
1993: Jan R Mead; R A Burger; John D Morrey; RP Warren; K M Okleberry; Robert W Sidwell
Effect of immunomodulators in the hu-PBL-SCID mouse model.
Biotechnology therapeutics 1993;4(1-2):133-43.
1993: John D Morrey; M K Jackson; Thomas D Bunch; Robert W Sidwell
Activation of the human immunodeficiency virus type 1 long terminal repeat by skin-sensitizing chemicals in transgenic mice.
Intervirology 1993;36(2):65-71.
1992: John D Morrey; S M Bourn; Thomas D Bunch; Robert W Sidwell; C A Rosen
HIV-1 LTR activation model: evaluation of various agents in skin of transgenic mice.
Journal of acquired immune deficiency syndromes 1992;5(12):1195-203.
1992: Robert W Sidwell; M Hitchcock; K M Okleberry; R A Burger; RP Warren; John D Morrey
Suppression of murine retroviral disease by 2',3'-didehydro-2',3'-dideoxythymidine (D4T).
Antiviral research 1992;19(4):313-24.
1992: RP Warren; John D Morrey; R A Burger; K M Okleberry; Robert W Sidwell
Murine retroviral disease-enhancing effects of a pyrimidinone immunomodulator.
Antiviral research 1992;19(3):233-45.
1992: D F Smee; J L Morris; J A Leonhardt; Jan R Mead; A Holy; Robert W Sidwell
Treatment of murine cytomegalovirus infections in severe combined immunodeficient mice with ganciclovir, (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine, interferon, and bropirimine.
Antimicrobial agents and chemotherapy 1992;36(9):1837-42.
1992: RP Warren; R A Burger; Robert W Sidwell; L L Clark
Effect of triacontanol on numbers and functions of cells involved in inflammatory responses.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1992;200(3):349-52.
1992: Robert W Sidwell; JH Huffman; D F Smee; J Gilbert; A Gessaman; A Pease; RP Warren; J Huggins; M Kende
Potential role of immunomodulators for treatment of phlebovirus infections of animals.
Annals of the New York Academy of Sciences 1992;653():344-55.
1992: John D Morrey; Jan R Mead; RP Warren; K M Okleberry; R A Burger; Robert W Sidwell
Elucidation of mode of retroviral-inhibitory effects of imexon through use of immune competent and severe combined immune deficiency (SCID) mice.
Antiviral research 1992;17(3):223-33.
1992: Robert W Sidwell; JH Huffman; J Gilbert; B Moscon; G Pedersen; R Burger; RP Warren
Utilization of pulse oximetry for the study of the inhibitory effects of antiviral agents on influenza virus in mice.
Antimicrobial agents and chemotherapy 1992;36(2):473-6.
1992: Dale L Barnard; JH Huffman; J L Morris; S G Wood; B G Hughes; Robert W Sidwell
Evaluation of the antiviral activity of anthraquinones, anthrones and anthraquinone derivatives against human cytomegalovirus.
Antiviral research 1992;17(1):63-77.
1991: Jan R Mead; Michael J Arrowood; MC Healey; Robert W Sidwell
Cryptosporidial infections in SCID mice reconstituted with human or murine lymphocytes.
The Journal of protozoology 1991;38(6):59S-61S.
1991: D F Smee; R A Burger; J Coombs; JH Huffman; Robert W Sidwell
Progressive murine cytomegalovirus disease after termination of ganciclovir therapy in mice immunosuppressed by cyclophosphamide treatment.
The Journal of infectious diseases 1991;164(5):958-61.
1991: John D Morrey; S M Bourn; Thomas D Bunch; M K Jackson; Robert W Sidwell; L R Barrows; R A Daynes; C A Rosen
In vivo activation of human immunodeficiency virus type 1 long terminal repeat by UV type A (UV-A) light plus psoralen and UV-B light in the skin of transgenic mice.
Journal of virology 1991;65(9):5045-51.
1991: Jan R Mead; Michael J Arrowood; Robert W Sidwell; MC Healey
Chronic Cryptosporidium parvum infections in congenitally immunodeficient SCID and nude mice.
The Journal of infectious diseases 1991;163(6):1297-304.
1991: Jan R Mead; R A Burger; L J Yonk; J Coombs; RP Warren; M Kende; J Huggins; Robert W Sidwell
Effect of human, recombinant interleukin 2 on Punta Toro virus infections in C57BL/6 mice.
Antiviral research 1991;15(4):331-40.
1991: D F Smee; JH Huffman; A C Gessaman; J W Huggins; Robert W Sidwell
Prophylactic and therapeutic activities of 7-thia-8-oxoguanosine against Punta Toro virus infections in mice.
Antiviral research 1991;15(3):229-39.
1991: B B Barnett; N J Burns; K J Park; M I Dawson; M Kende; Robert W Sidwell
Antiviral immunotoxins: antibody-mediated delivery of gelonin inhibits Pichinde virus replication in vitro.
Antiviral research 1991;15(2):125-38.
1991: John D Morrey; RP Warren; K M Okleberry; R A Burger; M A Chirigos; Robert W Sidwell
Effect of imexon treatment on Friend virus complex infection using genetically defined mice as a model for HIV-1 infection.
Antiviral research 1991;15(1):51-65.
1991: John D Morrey; K M Okleberry; Robert W Sidwell
Early-initiated zidovudine therapy prevents disease but not low levels of persistent retrovirus in mice.
Journal of acquired immune deficiency syndromes 1991;4(5):506-12.
1990: RP Warren; Robert W Sidwell; JH Huffman; E W Call; MC Healey; A V Johnston; L A Radov; R J Murray; C R Kinsolving
Effect of oxamisole on immune parameters of mice infected with murine hepatitis.
International journal of immunopharmacology 1990;12(6):625-30.
1990: John D Morrey; RP Warren; K M Okleberry; R A Burger; M I Johnston; Robert W Sidwell
Effects of zidovudine on Friend virus complex infection in Rfv-3r/s genotype-containing mice used as a model for HIV infection.
Journal of acquired immune deficiency syndromes 1990;3(5):500-10.
1990: Robert W Sidwell; JH Huffman; T W Schafer; C Shipman
Influence of vehicle on topical efficacy of 2-acetylpyridine thiosemicarbazone and related derivatives on in vivo type 2 herpes simplex virus infections.
Chemotherapy 1990;36(1):58-69.
1988: Robert W Sidwell; JH Huffman; Dale L Barnard; D Y Pifat
Effects of ribamidine, a 3-carboxamidine derivative of ribavirin, on experimentally induced Phlebovirus infections.
Antiviral research 1988;10(4-5):193-207.
1988: N J Burns; B B Barnett; JH Huffman; M I Dawson; Robert W Sidwell; E De Clercq; M Kende
A newly developed immunofluorescent assay for determining the Pichinde virus-inhibitory effects of selected nucleoside analogues.
Antiviral research 1988;10(1-3):89-98.
1988: Robert W Sidwell; JH Huffman; B B Barnett; D Y Pifat
In vitro and in vivo Phlebovirus inhibition by ribavirin.
Antimicrobial agents and chemotherapy 1988;32(3):331-6.
1987: Robert W Sidwell; JH Huffman; E W Call; RP Warren; L A Radov; R J Murray
Inhibition of murine hepatitis virus infections by the immunomodulator 2,3,5,6,7,8-hexahydro-2-phenyl-8,8-dimethoxy-imidazo[1,2a]pyridine (PR-879-317A).
Antimicrobial agents and chemotherapy 1987;31(7):1130-4.
1987: Robert W Sidwell; JH Huffman; E Call; H Alaghamandan; G J Dixon
Effect of vidarabine in dimethyl sulfoxide vehicle on type 1 herpesvirus-induced cutaneous lesions in laboratory animals.
Chemotherapy 1987;33(2):141-50.
1987: RP Warren; MC Healey; A V Johnston; Robert W Sidwell; L A Radov; R J Murray; C R Kinsolving
PR 879-317A enhances in vitro immune activity of peripheral blood mononuclear cells from patients with Down syndrome.
International journal of immunopharmacology 1987;9(8):919-26.
1986: Robert W Sidwell; JH Huffman; E W Call; H Alaghamandan; Phillip Cook; R K Robins
Effect of selenazofurin on influenza A and B virus infections of mice.
Antiviral research 1986;6(6):343-53.
1985: Robert W Sidwell; JH Huffman; E W Call; H Alaghamandan; Phillip Cook; R K Robins
Activity of selenazofurin against influenza A and B viruses in vitro.
Antimicrobial agents and chemotherapy 1985;28(3):375-7.
1984: John D Morrey; Robert W Sidwell; R L Noble; B B Barnett; A W Mahoney
Effects of folic acid malnutrition on rotaviral infection in mice.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1984;176(1):77-83.
1983: R L Noble; Robert W Sidwell; A W Mahoney; B B Barnett; R S Spendlove
Influence of malnutrition and alterations in dietary protein on murine rotaviral disease.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1983;173(3):417-26.
1982: D F Smee; Robert W Sidwell; S M Clark; B B Barnett; R S Spendlove
Inhibition of rotaviruses by selected antiviral substances: mechanisms of viral inhibition and in vivo activity.
Antimicrobial agents and chemotherapy 1982;21(1):66-73.
1981: D F Smee; Robert W Sidwell; S M Clark; B B Barnett; R S Spendlove
Inhibition of bluetongue and Colorado tick fever orbiviruses by selected antiviral substances.
Antimicrobial agents and chemotherapy 1981;20(4):533-8.
1981: D F Smee; Robert W Sidwell; B B Barnett; R S Spendlove; R P Sharma
Development of antiviral levels of ribavirin in serum and urine of orally treated rats.
Chemotherapy 1981;27(1):12-7.
1981: D F Smee; Robert W Sidwell; B B Barnett; R S Spendlove
Bioassay system for determining ribavirin levels in human serum and urine.
Chemotherapy 1981;27(1):1-11.